Successful treatment of vancomycin-resistant Enterococcus faecium endocarditis with linezolid in a renal transplant recipient with human immunodeficiency virus infection

Transplant Infectious Disease

Volumn 6, Issue 3, 2004, Pages 117-119

  Archuleta, Sophia ^a,b   Murphy, B ^a   Keller, M J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Center for Special Studies   (United States)

Author keywords

Endocarditis; Linezolid; Renal transplants; Vancomycin resistant Enterococci

Indexed keywords

AMPICILLIN; ANTIRETROVIRUS AGENT; CYCLOSPORIN; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; GENTAMICIN; LINEZOLID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; STREPTOMYCIN; SULTAMICILLIN; VANCOMYCIN;

ADULT; ARTICLE; BACTERIAL ENDOCARDITIS; CASE REPORT; ENTEROCOCCUS FAECIUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; THROMBOCYTOPENIA;

ACETAMIDES; ANTI-INFECTIVE AGENTS; ENDOCARDITIS, BACTERIAL; ENTEROCOCCUS FAECIUM; GRAM-POSITIVE BACTERIAL INFECTIONS; HIV INFECTIONS; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; OXAZOLIDINONES; VANCOMYCIN RESISTANCE; VIRAL LOAD;

EID: 10944266071     PISSN: 13982273     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2004.00059.x     Document Type: Article

References (10)

1. PATERSON DL, DOMINGUEZ EA, CHANG FY, et al. Infective endocarditis in solid organ transplant recipients. Clin Infect Dis 1998: 26: 689-694.
2. ABBOTT KC, DURAN M, HYPOLITE I, et al. Hospitalizations for bacterial endocarditis after renal transplantation in the United States. J Nephrol 2001: 14: 353-360.
3. CLEMETT D, MARKHAM A. Linezolid. Drugs 2000: 59: 815-827.
4. PATEL R, ROUSE MS, PIPER KE, STECKELBERG JM. Linezolid therapy of vancomycin-resistant Enterococcus faecium experimental endocarditis. Antimicrob Agents Chemother 2001: 45: 621-623.
5. CHIEN JW, KUCIA ML, SALATA RA. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections. Clin Infect Dis 2000: 30: 146-151.
6. MATSUMURA SO, LOUIE L, LOUIE M, SIMOR AE. Synergy testing of vancomycin-resistant Enterococcus faecium against quinupristin-dalfopristin in combination with other antimicrobial agents. Antimicrob Agents Chemother 1999: 43: 2776-2779.
7. WAGENER MM,YU VL. Bacteremia in transplant recipients: a prospective study of demographics, etiologic agents, risk factors and outcomes. Am J Infect Control 1992: 20: 239-247.
8. Zyvox. In: MURRAY L, ed. Physician's Desk Reference. Montvale, NJ: Medical Economics Co., 2004: 2808-2815.
9. Linezolid (Zyvox). In: ABRAMOWICZ M, ed. The Medical Letter on Drugs and Therapeutics. New Rochelle, NY: The Medical Letter, Inc., Vol 42. 2000: 45-46.
10. GREEN SL, MADDOX JC, HUTTENBACH ED. Linezolid and reversible myelosuppression. JAMA 2001: 285: 1291.